Cargando…
Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis
Autores principales: | Li, Yao, Huang, Xiaojie, Chen, Hui, Qin, Yuanyuan, Hou, Jianhua, Li, Aixin, Wu, Hao, Yan, Xiaofeng, Chen, Yaokai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228906/ https://www.ncbi.nlm.nih.gov/pubmed/34167475 http://dx.doi.org/10.1186/s12879-021-06132-5 |
Ejemplares similares
-
The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis
por: Li, Yao, et al.
Publicado: (2020) -
Prevalence of cryptococcal antigen (CrAg) among HIV-positive patients in Eswatini, 2014–2015
por: Haumba, Samson M., et al.
Publicado: (2020) -
Using laboratory data to assess the impact of coronavirus (COVID-19) on reflex cryptococcal antigenaemia (CrAg) testing in South Africa
por: Cassim, Naseem, et al.
Publicado: (2023) -
1497. Cryptococcal Antigen Screening and Pre-emptive Fluconazole Therapy in HIV-infected Patients: A Multicenter, Retrospective Study in China
por: Lu, Yanqiu, et al.
Publicado: (2023) -
Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda
por: Ramachandran, Anu, et al.
Publicado: (2017)